Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Claims on tissue plasminogen activator.

R S Crespi1

  • 1Intellectual Property in Business, London, UK.

Nature
|January 26, 1989
PubMed
Summary
This summary is machine-generated.

A key patent for a recombinant protein product was invalidated twice in UK courts. This ruling could significantly impact intellectual property rights for biotechnology products.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An analysis of moral issues affecting patenting inventions in the life sciences: a European perspective.

Science and engineering ethics·2001
Same author

Genomics, proteomics and patents.

Trends in biotechnology·2001
Same author

Patents on genes: clarifying the issues.

Nature biotechnology·2000
Same author

The Biotechnology Patent Directive is approved at last!

Trends in biotechnology·1999
Same author

Intellectual property, GATT and harmonization.

Trends in biotechnology·1994
Same author

Protecting biotechnological inventions.

Trends in biotechnology·1994
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
See all related articles

Area of Science:

  • Biotechnology
  • Intellectual Property Law
  • Pharmaceuticals

Background:

  • Patents are crucial for protecting innovations in the pharmaceutical and biotechnology sectors.
  • Recombinant protein products represent a significant area of biopharmaceutical development.
  • Legal challenges to foundational patents can disrupt market exclusivity and innovation.

Purpose of the Study:

  • To analyze the implications of a 'master' patent on a recombinant protein product being overturned in British courts.
  • To assess the potential consequences for intellectual property rights and the biotechnology industry.

Main Methods:

  • Review of British court rulings concerning a specific recombinant protein patent.
  • Analysis of legal precedents and arguments presented in the court cases.

Related Experiment Videos

  • Examination of the potential impact on patent law and biopharmaceutical commercialization.

    • Main Results:

    • The 'master' patent for the recombinant protein product was invalidated on two separate occasions by British courts.
    • The legal challenges centered on the patentability and scope of the recombinant protein technology.

    Conclusions:

    • The repeated overturning of this significant patent raises questions about the enforceability of existing intellectual property in biotechnology.
    • The far-reaching consequences may include a reevaluation of patent strategies and potential impacts on investment in the biopharmaceutical sector.